Anticoagulation and Neuraxial/Peripheral Anesthesia

Mudit Kaushal, Ryan E. Rubin, Alan D. Kaye, Karina Gritsenko

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Novel anticoagulants (NAGs) have emerged as the preferred alternatives to vitamin K antagonists. In patients being considered for regional anesthesia, these drugs present a layer of complexity in the preprocedure evaluation. There are no established tests to monitor anticoagulant activity and our experience is short with these drugs. These authors believe it is important to review the relevant hematology, orthopedics, and anesthesiology literature to provide a valuable reference for the clinician who is met with these challenges. In addition to discussing NAGs, we also review the existing American Society of Regional Anesthesia guidelines for heparin, low-molecular-weight heparin, and antiplatelet agents.

Original languageEnglish (US)
Pages (from-to)e21-e39
JournalAnesthesiology Clinics
Volume35
Issue number2
DOIs
StatePublished - Jun 1 2017

Fingerprint

Anticoagulants
Conduction Anesthesia
Anesthesia
Anesthesiology
Vitamin K
Low Molecular Weight Heparin
Platelet Aggregation Inhibitors
Hematology
Pharmaceutical Preparations
Orthopedics
Heparin
Guidelines

Keywords

  • Anticoagulation
  • Antiplatelet
  • Coumadin
  • Direct thrombin inhibitors
  • Factor Xa inhibitors
  • Neuraxial
  • Regional

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Anticoagulation and Neuraxial/Peripheral Anesthesia. / Kaushal, Mudit; Rubin, Ryan E.; Kaye, Alan D.; Gritsenko, Karina.

In: Anesthesiology Clinics, Vol. 35, No. 2, 01.06.2017, p. e21-e39.

Research output: Contribution to journalReview article

Kaushal, Mudit ; Rubin, Ryan E. ; Kaye, Alan D. ; Gritsenko, Karina. / Anticoagulation and Neuraxial/Peripheral Anesthesia. In: Anesthesiology Clinics. 2017 ; Vol. 35, No. 2. pp. e21-e39.
@article{ee726be733ea45449e2152603ae4fd1f,
title = "Anticoagulation and Neuraxial/Peripheral Anesthesia",
abstract = "Novel anticoagulants (NAGs) have emerged as the preferred alternatives to vitamin K antagonists. In patients being considered for regional anesthesia, these drugs present a layer of complexity in the preprocedure evaluation. There are no established tests to monitor anticoagulant activity and our experience is short with these drugs. These authors believe it is important to review the relevant hematology, orthopedics, and anesthesiology literature to provide a valuable reference for the clinician who is met with these challenges. In addition to discussing NAGs, we also review the existing American Society of Regional Anesthesia guidelines for heparin, low-molecular-weight heparin, and antiplatelet agents.",
keywords = "Anticoagulation, Antiplatelet, Coumadin, Direct thrombin inhibitors, Factor Xa inhibitors, Neuraxial, Regional",
author = "Mudit Kaushal and Rubin, {Ryan E.} and Kaye, {Alan D.} and Karina Gritsenko",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/j.anclin.2017.01.002",
language = "English (US)",
volume = "35",
pages = "e21--e39",
journal = "Anesthesiology Clinics",
issn = "1932-2275",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Anticoagulation and Neuraxial/Peripheral Anesthesia

AU - Kaushal, Mudit

AU - Rubin, Ryan E.

AU - Kaye, Alan D.

AU - Gritsenko, Karina

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Novel anticoagulants (NAGs) have emerged as the preferred alternatives to vitamin K antagonists. In patients being considered for regional anesthesia, these drugs present a layer of complexity in the preprocedure evaluation. There are no established tests to monitor anticoagulant activity and our experience is short with these drugs. These authors believe it is important to review the relevant hematology, orthopedics, and anesthesiology literature to provide a valuable reference for the clinician who is met with these challenges. In addition to discussing NAGs, we also review the existing American Society of Regional Anesthesia guidelines for heparin, low-molecular-weight heparin, and antiplatelet agents.

AB - Novel anticoagulants (NAGs) have emerged as the preferred alternatives to vitamin K antagonists. In patients being considered for regional anesthesia, these drugs present a layer of complexity in the preprocedure evaluation. There are no established tests to monitor anticoagulant activity and our experience is short with these drugs. These authors believe it is important to review the relevant hematology, orthopedics, and anesthesiology literature to provide a valuable reference for the clinician who is met with these challenges. In addition to discussing NAGs, we also review the existing American Society of Regional Anesthesia guidelines for heparin, low-molecular-weight heparin, and antiplatelet agents.

KW - Anticoagulation

KW - Antiplatelet

KW - Coumadin

KW - Direct thrombin inhibitors

KW - Factor Xa inhibitors

KW - Neuraxial

KW - Regional

UR - http://www.scopus.com/inward/record.url?scp=85019639466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019639466&partnerID=8YFLogxK

U2 - 10.1016/j.anclin.2017.01.002

DO - 10.1016/j.anclin.2017.01.002

M3 - Review article

VL - 35

SP - e21-e39

JO - Anesthesiology Clinics

JF - Anesthesiology Clinics

SN - 1932-2275

IS - 2

ER -